The Use of Traditional Chemotherapy in Lung Cancer

Many of us are on a tyrosine kinase inhibitor (TKI), however there are definite benefits to the use of traditional chemotherapy (chemo). In this article, we will learn a little more about this treatment option.

Kirk SmithNovember 9, 2020

The Two Most Surprising Risk Factors for Lung Cancer

Worldwide about 2,100,000 people are diagnosed with lung cancer every year. Approximately 85% of them have used tobacco products. Most are older and in poor health. It’s an insidious disease that few people survive long term.

Kirk SmithNovember 9, 2020

ALK Positive Will Be Funding Two New Clinical Trials!

November is Lung Cancer Awareness Month, which it is a good time to reflect on our successes as an organization. In 2020, we were excited to announce that the ALK Positive/LUNGevity Research Fund will be funding clinical trials for the first time. It means that the money we have donated and raised is going toward patient studies that have the direct potential to extend our own lives.

Kirk SmithNovember 9, 2020

Fundraising Tips

ALK Positive is partnering with LUNGevity’s fundraising platform to crowdfund this November for Lung Cancer Awareness Month. Let’s get creative! Fundraisers of all kinds are successful including Celebrations, Athletics, In Memoriams, and DIY Events. The ALK Positive Fundraising Team is here to help! Have Questions? Email us at fundraising@alkpositive.org for personalized coaching.

Guest UserOctober 21, 2020

Lung Cancer Research Awards funded by ALK Positive Patient Group in Second Collaboration with LUNGevity Foundation

ALK-positive lung cancer patients continue to fund research relevant to their survival

Kirk SmithSeptember 23, 2020

SIDE EFFECTS COMPILATION & COMPARISON

IMPORTANT: This table is a list of various side effects members have shared. Please remember, this is NOT a medical document. Please use it as a guide and a starting point. Please consult your medical team for specific advice!

Guest UserSeptember 22, 2020

ALK patients with high PD-L1 expression and immunotherapy

Many of our members are wondering if immunotherapy with current checkpoint inhibitors may be a good idea for them if they have been diagnosed with a high PD-L1 expression. Spoiler alert: it is a bad idea for most. Read on to find out why.

Kirk SmithSeptember 22, 2020

ALK Positive Clinical Trials and Interview with multi-clinical ALK trial participant, Hazel Senz

Member Hazel Senz from Golden, CO shares her experiences from participating in multiple ALK clinical trials and how they have affected the course of her disease.

Kirk SmithSeptember 18, 2020

What is Leptomeningeal Disease and how is it treated?

A number of our members deal with leptomeningeal disease (LMD) at some point in their diagnosis. Read more on what LMD is and how it is treated.

Kirk SmithSeptember 15, 2020

Patient Spotlight: Heather Smith, Denver CO

We interviewed our member and ‘living and thriving with lung cancer’ advocate, Heather Smith, on living a full, fulfilling life in the ‘new normal’ of a lung cancer diagnosis.

Kirk SmithSeptember 15, 2020

ALK Positive Members Making the Best of COVID-19 Stay-at-Home Orders

ALK Positives share through photos how they are coping with stay-at-home orders during COVID.

Cori CasebeerJuly 1, 2020

ALK-positive Lung Cancer and COVID-19: Update

The novel coronavirus is a real and deadly threat to those with lung cancer. Learn what the recent studies say about your risk and how to stay as safe as possible.

Cori CasebeerJuly 1, 2020